These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33375115)

  • 1. Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and
    Konecny J; Misiachna A; Hrabinova M; Pulkrabkova L; Benkova M; Prchal L; Kucera T; Kobrlova T; Finger V; Kolcheva M; Kortus S; Jun D; Valko M; Horak M; Soukup O; Korabecny J
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
    Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease.
    Hepnarova V; Korabecny J; Matouskova L; Jost P; Muckova L; Hrabinova M; Vykoukalova N; Kerhartova M; Kucera T; Dolezal R; Nepovimova E; Spilovska K; Mezeiova E; Pham NL; Jun D; Staud F; Kaping D; Kuca K; Soukup O
    Eur J Med Chem; 2018 Apr; 150():292-306. PubMed ID: 29533874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Sokolov VB; Grigoriev VV; Serebryakova OG; Vikhareva EA; Aksinenko AY; Barreto GE; Aliev G; Bachurin SO
    Sci Rep; 2015 Aug; 5():13164. PubMed ID: 26281952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies.
    Mamun AA; Pidaný F; Hulcová D; Maříková J; Kučera T; Schmidt M; Catapano MC; Hrabinová M; Jun D; Múčková L; Kuneš J; Janoušek J; Andrýs R; Nováková L; Peřinová R; Maafi N; Soukup O; Korábečný J; Cahlíková L
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
    Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
    Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
    Jasiecki J; Wasąg B
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
    [No Abstract]   [Full Text] [Related]  

  • 12. In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
    Ul-Haq Z; Khan W; Kalsoom S; Ansari FL
    Theor Biol Med Model; 2010 Jun; 7():22. PubMed ID: 20550720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain Barrier.
    Chlebek J; Korábečný J; Doležal R; Štěpánková Š; Pérez DI; Hošťálková A; Opletal L; Cahlíková L; Macáková K; Kučera T; Hrabinová M; Jun D
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
    Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
    Gonzalez J; Ramirez J; Schwans JP
    Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
    ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
    Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D
    Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease.
    Mezeiova E; Prchal L; Hrabinova M; Muckova L; Pulkrabkova L; Soukup O; Misiachna A; Janousek J; Fibigar J; Kucera T; Horak M; Makhaeva GF; Korabecny J
    Biomed Pharmacother; 2024 Apr; 173():116399. PubMed ID: 38492439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.